Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The anticardiolipin syndrome.

T Danao1, E G Camara

  • 1Cleveland Clinic Foundation, Ohio.

American Family Physician
|January 1, 1989
PubMed
Summary

Anticardiolipin antibodies are linked to a syndrome causing blood clots, low platelets, and pregnancy loss, often with autoimmune disorders. Diagnosis is improving with new tests, but treatments like prednisone and aspirin remain debated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Premenstrual syndrome: a guide for the clinician.

Hawaii medical journal·1994
Same author

Nitrogen mustard as induction therapy for rheumatoid arthritis: clinical and immunologic effects.

The Journal of rheumatology·1992
Same author

Chronic fatigue syndrome.

American family physician·1992
Same author

Chronic fatigue and immune dysfunction.

Cleveland Clinic journal of medicine·1992
Same author

Ophthalmologic effects of psychotropic medications.

Psychosomatics·1992
Same author

Methotrexate for systemic lupus erythematosus: a retrospective analysis of 17 unselected cases.

Clinical and experimental rheumatology·1991

Area of Science:

  • Immunology
  • Hematology
  • Obstetrics & Gynecology

Background:

  • Anticardiolipin antibodies are associated with a distinct clinical syndrome.
  • This syndrome involves venous and arterial thrombosis, thrombocytopenia, and recurrent fetal loss.
  • Autoimmune diseases frequently accompany this condition.

Purpose of the Study:

  • To describe the characteristics of anticardiolipin antibody syndrome.
  • To highlight the availability of a standardized diagnostic test.
  • To discuss current and potential treatment strategies.

Main Methods:

  • Utilizes a standardized enzyme immunoassay for anticardiolipin antibody detection.
  • Reviews existing literature on clinical manifestations and treatment outcomes.
  • Analyzes patient data related to thrombosis and fetal loss.

Main Results:

  • A standardized enzyme immunoassay for anticardiolipin antibodies is now widely available.
  • Treatment strategies, particularly for pregnant patients, are controversial.
  • Prednisone and aspirin are used in pregnant patients; anticoagulation is recommended for thrombosis.

Conclusions:

  • Anticardiolipin antibody syndrome is a significant clinical entity requiring further research.
  • Standardized testing aids in diagnosis and management.
  • Optimal treatment protocols, including the role of plasmapheresis and cytotoxic agents, require further investigation.

Related Experiment Videos